Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The acetylcholine receptor gamma subunit (AChR γ-subunit) is a protein component of the nicotinic acetylcholine receptor (nAChR), specifically found in skeletal muscle. Encoded by the CHRNG gene, this subunit is part of a ligand-gated ion channel mediating synaptic transmission at neuromuscular junctions, enabling communication between nerve and muscle cells essential for movement. The γ-subunit is present in fetal muscle and is later replaced by the ε-subunit in adult muscle. It plays a critical role in the formation of AChR clusters during development. Mutations in CHRNG can cause congenital myasthenic syndromes.
Agonist binding leading to ion channel opening and subsequent muscle cell depolarization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Receptor Gamma Subunit (None).